[{"id":2714,"name":"Elekta and GE HealthCare’s MIM Software enter significant collaboration to deliver leading cancer treatment planning solutions","url":"https://ir.elekta.com/investors/press-releases/2024/elekta-and-ge-healthcares-mim-software-enter-significant-collaboration-to-deliver-leading-cancer-treatment-planning-solutions/","date":"2024-04-22T11:00:00.000Z","intro":"<p><strong>Strategic collaboration to develop advanced vendor-agnostic radiation oncology treatment applications using industry-leading auto-contouring and treatment planning software solutions</strong></p>","regulatory":false},{"id":2710,"name":"Invitation to investor meeting at ESTRO 2024 in Glasgow","url":"https://ir.elekta.com/investors/press-releases/2024/invitation-to-investor-meeting-at-estro-2024-in-glasgow/","date":"2024-03-28T11:00:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a meeting in conjunction with ESTRO 2024 in Glasgow, United Kingdom.</strong></p>","regulatory":false},{"id":2708,"name":"Elekta partners with MSD to enhance kidney cancer care using digital solutions","url":"https://ir.elekta.com/investors/press-releases/2024/elekta-partners-with-msd-to-enhance-kidney-cancer-care-using-digital-solutions/","date":"2024-03-28T06:30:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta (EKTA-B.ST) today announced a partnership with MSD (Merck &amp; Co., Inc., Rahway, N.J., USA) to develop digital patient monitoring for people with advanced renal cell carcinoma (RCC), using Elekta’s Kaiku Health solution, a digital platform for patient engagement and reported outcomes monitoring.</strong></p>","regulatory":false},{"id":2683,"name":"Elekta announces resignation of Board Member Kelly Londy","url":"https://ir.elekta.com/investors/press-releases/2024/elekta-announces-resignation-of-board-member-kelly-londy/","date":"2024-03-01T15:45:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta AB (EKTA-B.ST), a global leader in precision radiation therapy, today announced that Kelly Londy, Member of the Board, will step down from her position and all board responsibilities, effective today, March 1, 2024.</strong></p>","regulatory":false},{"id":2680,"name":"Interim report, May–January 2023/24","url":"https://ir.elekta.com/investors/press-releases/2024/interim-report-mayjanuary-202324/","date":"2024-02-29T06:30:00.000Z","intro":"<p><strong>Profitable growth and record cash flow</strong></p>","regulatory":true}]